Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis

Surviving expression might serve as a prognostic biomarker predicting the clinical outcome of non-small cell lung cancer (NSCLC). The study was conducted to explore the potential correlation of survivin protein expression with NSCLC and its clinicopathologic characteristics. PubMed, Medline, Cochran...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC cancer 2016-04, Vol.16 (276), p.276-276, Article 276
Hauptverfasser: Duan, Liang, Hu, Xuefei, Jin, Yuxing, Liu, Ruijun, You, Qingjun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 276
container_issue 276
container_start_page 276
container_title BMC cancer
container_volume 16
creator Duan, Liang
Hu, Xuefei
Jin, Yuxing
Liu, Ruijun
You, Qingjun
description Surviving expression might serve as a prognostic biomarker predicting the clinical outcome of non-small cell lung cancer (NSCLC). The study was conducted to explore the potential correlation of survivin protein expression with NSCLC and its clinicopathologic characteristics. PubMed, Medline, Cochrane Library, CNKI and Wanfang database were searched through January 2016 with a set of inclusion and exclusion criteria. Data was extracted from these articles and all statistical analysis was conducted by using Stata 12.0. A total of 28 literatures (14 studies in Chinese and 14 studies in English) were enrolled in this meta-analysis, including 3206 NSCLC patients and 816 normal controls. The result of meta-analysis demonstrated a significant difference of survivin positive expression between NSCLC patients and normal controls (RR = 7.16, 95 % CI = 4.63-11.07, P < 0.001). To investigate the relationship of survivin expression and clinicopathologic characteristics, we performed a meta-analysis in NSCLC patients. Our results indicates survivin expression was associated with histological differentiation, tumor-node-metastasis (TNM) stage and lymph node metastasis (LNM) (RR = 0.80, 95 % CI = 0.73-0.87, P < 0.001; RR = 0.75, 95 % CI = 0.67-0.84, P < 0.001; RR = 1.14, 95 % CI = 1.01-1.29, P = 0.035, respectively), but not pathological type and tumor size. (RR = 1.00, 95 % CI = 0.93-1.07, P = 0.983; RR = 0.95, 95 % CI = 0.86-1.05, P = 0.336, respectively). Higher expression of survivin in NSCLC patients was found when compared to normal controls. Survivin expression was associated with the clinicopathologic characteristics of NSCLC and may serves as an important biomarker for NSCLC progression.
doi_str_mv 10.1186/s12885-016-2304-3
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4836165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A450238251</galeid><sourcerecordid>A450238251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-7814d65560d4d4d8511cac4c70b5e5572f51ef6c51b18d58b6c7d93a01ea68bd3</originalsourceid><addsrcrecordid>eNptkl1rFTEQhhdRbK3-AG9kQRC92JpsNtnUC-FQ_CgUBKvXIZudPSeSTY6Z7NL-e7OctpwFGcgMmecdyOQtiteUnFMqxUektZS8IlRUNSNNxZ4Up7RpaVU3pH16VJ8ULxD_EEJbSeTz4qRuyQVhUpwWeDPF2c7Wl_sYEuQMt_sIiDb40mJp_RzcDH0uyrSDhdo-tMNQ-uArHLVzpYF8uMlvS6O9gbgINmi1x0-lLkdIutJeuzu0-LJ4NmiH8Oo-nxW_v375dfm9uv7x7epyc10ZzmiqWkmbXnAuSN_kkJxSo01jWtJx4LytB05hEIbTjsqey06Ytr9gmlDQQnY9Oys-H-bup26E3oBPUTu1j3bU8U4FbdW64-1ObcOsGskEFTwPeH8_IIa_E2BSo8XlodpDmFDlddaSNYK0GX17QLfagbJ-CHmiWXC1aTipmaw5zdT5f6gcPYzWBA-DzfcrwYeVIDMJbtNWT4jq6ubnmn13xO5Au7TD4KaU_wrXID2AJgbECMPjSihRi7HUwVgqG0stxlIsa94c7_JR8eAk9g_tishV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1782834607</pqid></control><display><type>article</type><title>Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Duan, Liang ; Hu, Xuefei ; Jin, Yuxing ; Liu, Ruijun ; You, Qingjun</creator><creatorcontrib>Duan, Liang ; Hu, Xuefei ; Jin, Yuxing ; Liu, Ruijun ; You, Qingjun</creatorcontrib><description>Surviving expression might serve as a prognostic biomarker predicting the clinical outcome of non-small cell lung cancer (NSCLC). The study was conducted to explore the potential correlation of survivin protein expression with NSCLC and its clinicopathologic characteristics. PubMed, Medline, Cochrane Library, CNKI and Wanfang database were searched through January 2016 with a set of inclusion and exclusion criteria. Data was extracted from these articles and all statistical analysis was conducted by using Stata 12.0. A total of 28 literatures (14 studies in Chinese and 14 studies in English) were enrolled in this meta-analysis, including 3206 NSCLC patients and 816 normal controls. The result of meta-analysis demonstrated a significant difference of survivin positive expression between NSCLC patients and normal controls (RR = 7.16, 95 % CI = 4.63-11.07, P &lt; 0.001). To investigate the relationship of survivin expression and clinicopathologic characteristics, we performed a meta-analysis in NSCLC patients. Our results indicates survivin expression was associated with histological differentiation, tumor-node-metastasis (TNM) stage and lymph node metastasis (LNM) (RR = 0.80, 95 % CI = 0.73-0.87, P &lt; 0.001; RR = 0.75, 95 % CI = 0.67-0.84, P &lt; 0.001; RR = 1.14, 95 % CI = 1.01-1.29, P = 0.035, respectively), but not pathological type and tumor size. (RR = 1.00, 95 % CI = 0.93-1.07, P = 0.983; RR = 0.95, 95 % CI = 0.86-1.05, P = 0.336, respectively). Higher expression of survivin in NSCLC patients was found when compared to normal controls. Survivin expression was associated with the clinicopathologic characteristics of NSCLC and may serves as an important biomarker for NSCLC progression.</description><identifier>ISSN: 1471-2407</identifier><identifier>EISSN: 1471-2407</identifier><identifier>DOI: 10.1186/s12885-016-2304-3</identifier><identifier>PMID: 27090386</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Analysis ; Biomarkers, Tumor - biosynthesis ; Biomarkers, Tumor - genetics ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - pathology ; Care and treatment ; Complications and side effects ; Development and progression ; Gene expression ; Gene Expression Regulation, Neoplastic ; Humans ; Inhibitor of Apoptosis Proteins - biosynthesis ; Inhibitor of Apoptosis Proteins - genetics ; Lung cancer, Non-small cell ; Lymphatic Metastasis - genetics ; Lymphatic Metastasis - pathology ; Meta-analysis ; Neoplasm Staging ; Prognosis</subject><ispartof>BMC cancer, 2016-04, Vol.16 (276), p.276-276, Article 276</ispartof><rights>COPYRIGHT 2016 BioMed Central Ltd.</rights><rights>Duan et al. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-7814d65560d4d4d8511cac4c70b5e5572f51ef6c51b18d58b6c7d93a01ea68bd3</citedby><cites>FETCH-LOGICAL-c531t-7814d65560d4d4d8511cac4c70b5e5572f51ef6c51b18d58b6c7d93a01ea68bd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836165/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836165/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27090386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duan, Liang</creatorcontrib><creatorcontrib>Hu, Xuefei</creatorcontrib><creatorcontrib>Jin, Yuxing</creatorcontrib><creatorcontrib>Liu, Ruijun</creatorcontrib><creatorcontrib>You, Qingjun</creatorcontrib><title>Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis</title><title>BMC cancer</title><addtitle>BMC Cancer</addtitle><description>Surviving expression might serve as a prognostic biomarker predicting the clinical outcome of non-small cell lung cancer (NSCLC). The study was conducted to explore the potential correlation of survivin protein expression with NSCLC and its clinicopathologic characteristics. PubMed, Medline, Cochrane Library, CNKI and Wanfang database were searched through January 2016 with a set of inclusion and exclusion criteria. Data was extracted from these articles and all statistical analysis was conducted by using Stata 12.0. A total of 28 literatures (14 studies in Chinese and 14 studies in English) were enrolled in this meta-analysis, including 3206 NSCLC patients and 816 normal controls. The result of meta-analysis demonstrated a significant difference of survivin positive expression between NSCLC patients and normal controls (RR = 7.16, 95 % CI = 4.63-11.07, P &lt; 0.001). To investigate the relationship of survivin expression and clinicopathologic characteristics, we performed a meta-analysis in NSCLC patients. Our results indicates survivin expression was associated with histological differentiation, tumor-node-metastasis (TNM) stage and lymph node metastasis (LNM) (RR = 0.80, 95 % CI = 0.73-0.87, P &lt; 0.001; RR = 0.75, 95 % CI = 0.67-0.84, P &lt; 0.001; RR = 1.14, 95 % CI = 1.01-1.29, P = 0.035, respectively), but not pathological type and tumor size. (RR = 1.00, 95 % CI = 0.93-1.07, P = 0.983; RR = 0.95, 95 % CI = 0.86-1.05, P = 0.336, respectively). Higher expression of survivin in NSCLC patients was found when compared to normal controls. Survivin expression was associated with the clinicopathologic characteristics of NSCLC and may serves as an important biomarker for NSCLC progression.</description><subject>Analysis</subject><subject>Biomarkers, Tumor - biosynthesis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Care and treatment</subject><subject>Complications and side effects</subject><subject>Development and progression</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Inhibitor of Apoptosis Proteins - biosynthesis</subject><subject>Inhibitor of Apoptosis Proteins - genetics</subject><subject>Lung cancer, Non-small cell</subject><subject>Lymphatic Metastasis - genetics</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Meta-analysis</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><issn>1471-2407</issn><issn>1471-2407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkl1rFTEQhhdRbK3-AG9kQRC92JpsNtnUC-FQ_CgUBKvXIZudPSeSTY6Z7NL-e7OctpwFGcgMmecdyOQtiteUnFMqxUektZS8IlRUNSNNxZ4Up7RpaVU3pH16VJ8ULxD_EEJbSeTz4qRuyQVhUpwWeDPF2c7Wl_sYEuQMt_sIiDb40mJp_RzcDH0uyrSDhdo-tMNQ-uArHLVzpYF8uMlvS6O9gbgINmi1x0-lLkdIutJeuzu0-LJ4NmiH8Oo-nxW_v375dfm9uv7x7epyc10ZzmiqWkmbXnAuSN_kkJxSo01jWtJx4LytB05hEIbTjsqey06Ytr9gmlDQQnY9Oys-H-bup26E3oBPUTu1j3bU8U4FbdW64-1ObcOsGskEFTwPeH8_IIa_E2BSo8XlodpDmFDlddaSNYK0GX17QLfagbJ-CHmiWXC1aTipmaw5zdT5f6gcPYzWBA-DzfcrwYeVIDMJbtNWT4jq6ubnmn13xO5Au7TD4KaU_wrXID2AJgbECMPjSihRi7HUwVgqG0stxlIsa94c7_JR8eAk9g_tishV</recordid><startdate>20160418</startdate><enddate>20160418</enddate><creator>Duan, Liang</creator><creator>Hu, Xuefei</creator><creator>Jin, Yuxing</creator><creator>Liu, Ruijun</creator><creator>You, Qingjun</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160418</creationdate><title>Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis</title><author>Duan, Liang ; Hu, Xuefei ; Jin, Yuxing ; Liu, Ruijun ; You, Qingjun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-7814d65560d4d4d8511cac4c70b5e5572f51ef6c51b18d58b6c7d93a01ea68bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Analysis</topic><topic>Biomarkers, Tumor - biosynthesis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Care and treatment</topic><topic>Complications and side effects</topic><topic>Development and progression</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Inhibitor of Apoptosis Proteins - biosynthesis</topic><topic>Inhibitor of Apoptosis Proteins - genetics</topic><topic>Lung cancer, Non-small cell</topic><topic>Lymphatic Metastasis - genetics</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Meta-analysis</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duan, Liang</creatorcontrib><creatorcontrib>Hu, Xuefei</creatorcontrib><creatorcontrib>Jin, Yuxing</creatorcontrib><creatorcontrib>Liu, Ruijun</creatorcontrib><creatorcontrib>You, Qingjun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duan, Liang</au><au>Hu, Xuefei</au><au>Jin, Yuxing</au><au>Liu, Ruijun</au><au>You, Qingjun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis</atitle><jtitle>BMC cancer</jtitle><addtitle>BMC Cancer</addtitle><date>2016-04-18</date><risdate>2016</risdate><volume>16</volume><issue>276</issue><spage>276</spage><epage>276</epage><pages>276-276</pages><artnum>276</artnum><issn>1471-2407</issn><eissn>1471-2407</eissn><abstract>Surviving expression might serve as a prognostic biomarker predicting the clinical outcome of non-small cell lung cancer (NSCLC). The study was conducted to explore the potential correlation of survivin protein expression with NSCLC and its clinicopathologic characteristics. PubMed, Medline, Cochrane Library, CNKI and Wanfang database were searched through January 2016 with a set of inclusion and exclusion criteria. Data was extracted from these articles and all statistical analysis was conducted by using Stata 12.0. A total of 28 literatures (14 studies in Chinese and 14 studies in English) were enrolled in this meta-analysis, including 3206 NSCLC patients and 816 normal controls. The result of meta-analysis demonstrated a significant difference of survivin positive expression between NSCLC patients and normal controls (RR = 7.16, 95 % CI = 4.63-11.07, P &lt; 0.001). To investigate the relationship of survivin expression and clinicopathologic characteristics, we performed a meta-analysis in NSCLC patients. Our results indicates survivin expression was associated with histological differentiation, tumor-node-metastasis (TNM) stage and lymph node metastasis (LNM) (RR = 0.80, 95 % CI = 0.73-0.87, P &lt; 0.001; RR = 0.75, 95 % CI = 0.67-0.84, P &lt; 0.001; RR = 1.14, 95 % CI = 1.01-1.29, P = 0.035, respectively), but not pathological type and tumor size. (RR = 1.00, 95 % CI = 0.93-1.07, P = 0.983; RR = 0.95, 95 % CI = 0.86-1.05, P = 0.336, respectively). Higher expression of survivin in NSCLC patients was found when compared to normal controls. Survivin expression was associated with the clinicopathologic characteristics of NSCLC and may serves as an important biomarker for NSCLC progression.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>27090386</pmid><doi>10.1186/s12885-016-2304-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2407
ispartof BMC cancer, 2016-04, Vol.16 (276), p.276-276, Article 276
issn 1471-2407
1471-2407
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4836165
source MEDLINE; DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Analysis
Biomarkers, Tumor - biosynthesis
Biomarkers, Tumor - genetics
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - pathology
Care and treatment
Complications and side effects
Development and progression
Gene expression
Gene Expression Regulation, Neoplastic
Humans
Inhibitor of Apoptosis Proteins - biosynthesis
Inhibitor of Apoptosis Proteins - genetics
Lung cancer, Non-small cell
Lymphatic Metastasis - genetics
Lymphatic Metastasis - pathology
Meta-analysis
Neoplasm Staging
Prognosis
title Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A50%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survivin%20protein%20expression%20is%20involved%20in%20the%20progression%20of%20non-small%20cell%20lung%20cancer%20in%20Asians:%20a%20meta-analysis&rft.jtitle=BMC%20cancer&rft.au=Duan,%20Liang&rft.date=2016-04-18&rft.volume=16&rft.issue=276&rft.spage=276&rft.epage=276&rft.pages=276-276&rft.artnum=276&rft.issn=1471-2407&rft.eissn=1471-2407&rft_id=info:doi/10.1186/s12885-016-2304-3&rft_dat=%3Cgale_pubme%3EA450238251%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1782834607&rft_id=info:pmid/27090386&rft_galeid=A450238251&rfr_iscdi=true